Pier Capital, LLC Heron Therapeutics, Inc. Transaction History

Pier Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $3.34 Million - $8.02 Million	-326,574 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $978,742 - $1.5 Million	56,185 Added 20.78%	326,574 $7.67 Million
Q3 2019 Nov 13, 2019	BUY	$16.36 - $21.39 $161,947 - $211,739	9,899 Added 3.8%	270,389 $5 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $152,776 - $236,609	-9,024 Reduced 3.35%	260,490 $4.84 Million
Q1 2019 Apr 24, 2019	BUY	$23.15 - $28.34 $368,409 - $451,002	15,914 Added 6.28%	269,514 $6.59 Million
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $184,391 - $267,923	-8,370 Reduced 3.2%	253,600 $6.58 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $7.86 Million - $10.7 Million	261,970 New	261,970 $8.29 Million

178

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $186M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.